Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

CUSIP: 78667J108

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
Shares outstanding
62,650,155
Total 13F shares
53,511,146
Share change
-4,750,626
Total reported value
$581,112,272
Put/Call ratio
24%
Price per share
$10.86
Number of holders
190
Value change
-$70,089,721
Number of buys
105
Number of sells
92

Quarterly Holders Quick Answers

What is CUSIP 78667J108?
CUSIP 78667J108 identifies SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q2 2024

As of 30 Jun 2024, Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by 190 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,511,146 shares. The largest 10 holders included VANGUARD GROUP INC, FMR LLC, RTW INVESTMENTS, LP, BlackRock Inc., Bellevue Group AG, STATE STREET CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and JPMORGAN CHASE & CO. This page lists 190 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.